Shanghai RAAS Blood Products Co Ltd Sustainability Reports
Shanghai RAAS Blood Products Co., Ltd. specializes in the research, development, manufacturing, and sale of plasma-derived biopharmaceutical therapeutics. Their primary product lines include human albumin, immunoglobulins, and human coagulation factors.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001T2CWX1
5 reports from 2017 to 2025
- Shanghai RAAS Blood Products Co Ltd 2025 Sustainability Report
- Shanghai RAAS Blood Products Co Ltd 2024 Sustainability Report
- Shanghai RAAS Blood Products Co Ltd 2023 Social Responsibility Report
- Shanghai RAAS Blood Products Co Ltd 2020 Annual Social Responsibility Report
- Shanghai RAAS Blood Products Co Ltd 2017 Social Responsibility Report